Liver cancer, especially hepatocellular carcinoma (HCC), imposes a substantial global disease burden. Accurate diagnosis and prognostic assessment directly influence treatment selection and patient survival, and pathological examination remains the gold standard for liver cancer diagnosis. Identifying diverse tissue components and pathological subtypes on histopathology slides is crucial for estimating postoperative recurrence risk and overall prognosis. However, most publicly available resources are still provided at the whole-slide image (WSI) level, and well-annotated datasets for fine-grained tissue component identification in liver cancer are scarce, which hinders reproducible model development and the deployment of quantitative analysis tools. To address this gap, we release HepatoBench, a patch-level image database for liver cancer with annotations for seven key tissue categories. Based on HepatoBench, we train and open-source a deep learning classification model as a tissue recognition tool. Furthermore, we train a WSI-level tumor/non-tumor segmentation model to automatically localize lesion regions across entire slides. By integrating the patch-level tissue classifier with
Liver cancer is a leading cause of cancer-related mortality worldwide, with its high genetic heterogeneity complicating diagnosis and treatment. This study introduces DLSOM, a deep learning framework utilizing stacked autoencoders to analyze the complete somatic mutation landscape of 1,139 liver cancer samples, covering 20,356 protein-coding genes. By transforming high-dimensional mutation data into three low-dimensional features, DLSOM enables robust clustering and identifies five distinct liver cancer subtypes with unique mutational, functional, and biological profiles. Subtypes SC1 and SC2 exhibit higher mutational loads, while SC3 has the lowest, reflecting mutational heterogeneity. Novel and COSMIC-associated mutational signatures reveal subtype-specific molecular mechanisms, including links to hypermutation and chemotherapy resistance. Functional analyses further highlight the biological relevance of each subtype. This comprehensive framework advances precision medicine in liver cancer by enabling the development of subtype-specific diagnostics, biomarkers, and therapies, showcasing the potential of deep learning in addressing cancer complexity.
Primary liver malignancies are widely recognized as the most heterogeneous and prognostically diverse cancers of the digestive system. Among these, hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC) emerge as the two principal histological subtypes, demonstrating significantly greater complexity in tissue morphology and cellular architecture than other common tumors. The intricate representation of features in Whole Slide Images (WSIs) encompasses abundant crucial information for liver cancer histological subtyping, regarding hierarchical pyramid structure, tumor microenvironment (TME), and geometric representation. However, recent approaches have not adequately exploited these indispensable effective descriptors, resulting in a limited understanding of histological representation and suboptimal subtyping performance. To mitigate these limitations, ARGUS is proposed to advance histological subtyping in liver cancer by capturing the macro-meso-micro hierarchical information within the TME. Specifically, we first construct a micro-geometry feature to represent fine-grained cell-level pattern via a geometric structure across nuclei, thereby providing a more refin
Background: Liver cancer ranks as the fifth most common malignant tumor and the second most fatal in our country. Early diagnosis is crucial, necessitating that physicians identify liver cancer in patients at the earliest possible stage. However, the diagnostic process is complex and demanding. Physicians must analyze a broad spectrum of patient data, encompassing physical condition, symptoms, medical history, and results from various examinations and tests, recorded in both structured and unstructured medical formats. This results in a significant workload for healthcare professionals. In response, integrating knowledge graph technology to develop a liver cancer knowledge graph-assisted diagnosis and treatment system aligns with national efforts toward smart healthcare. Such a system promises to mitigate the challenges faced by physicians in diagnosing and treating liver cancer. Methods: This paper addresses the major challenges in building a knowledge graph for hepatocellular carcinoma diagnosis, such as the discrepancy between public data sources and real electronic medical records, the effective integration of which remains a key issue. The knowledge graph construction process
Precision therapy for liver cancer necessitates accurately delineating liver sub-regions to protect healthy tissue while targeting tumors, which is essential for reducing recurrence and improving survival rates. However, the segmentation of hepatic segments, known as Couinaud segmentation, is challenging due to indistinct sub-region boundaries and the need for extensive annotated datasets. This study introduces LiverFormer, a novel Couinaud segmentation model that effectively integrates global context with low-level local features based on a 3D hybrid CNN-Transformer architecture. Additionally, a registration-based data augmentation strategy is equipped to enhance the segmentation performance with limited labeled data. Evaluated on CT images from 123 patients, LiverFormer demonstrated high accuracy and strong concordance with expert annotations across various metrics, allowing for enhanced treatment planning for surgery and radiation therapy. It has great potential to reduces complications and minimizes potential damages to surrounding tissue, leading to improved outcomes for patients undergoing complex liver cancer treatments.
Liver cancer has a high incidence rate, but primary healthcare settings often lack experienced doctors. Advances in large models and AI technologies offer potential assistance. This work aims to address limitations in liver cancer diagnosis models, such as poor understanding of medical images, insufficient consideration of liver blood vessels, and ensuring accurate medical information. We propose a specialized diagnostic assistant to improve the diagnostic capabilities of less experienced doctors. Our framework combines large and small models, using optimized small models for precise patient image perception. Specifically, a segmentation network iteratively removes ambiguous pixels for liver tumor segmentation, and a multi-scale, multi-level differential network segments liver vessels. Features from these segmentations and medical records form a patient's personalized knowledge base. For diagnosis, Chain of Thought (COT) technology designs prompts mimicking experienced doctors' thought patterns, and Retrieval-Augmented Generation (RAG) technology provides answers based on reliable domain knowledge and trusted cases. Our small model methods improve liver tumor and vessel segmentatio
This paper proposes a novel multimodal deep learning framework integrating bidirectional LSTM, multi-head attention mechanism, and variational mode decomposition (BiLSTM-AM-VMD) for early liver cancer diagnosis. Using heterogeneous data that include clinical characteristics, biochemical markers, and imaging-derived variables, our approach improves both prediction accuracy and interpretability. Experimental results on real-world datasets demonstrate superior performance over traditional machine learning and baseline deep learning models.
The diagnosis of primary liver cancers (PLCs) can be challenging, especially on biopsies and for combined hepatocellular-cholangiocarcinoma (cHCC-CCA). We automatically classified PLCs on routine-stained biopsies using a weakly supervised learning method. Weak tumour/non-tumour annotations served as labels for training a Resnet18 neural network, and the network's last convolutional layer was used to extract new tumour tile features. Without knowledge of the precise labels of the malignancies, we then applied an unsupervised clustering algorithm. Our model identified specific features of hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (iCCA). Despite no specific features of cHCC-CCA being recognized, the identification of HCC and iCCA tiles within a slide could facilitate the diagnosis of primary liver cancers, particularly cHCC-CCA. Method and results: 166 PLC biopsies were divided into training, internal and external validation sets: 90, 29 and 47 samples. Two liver pathologists reviewed each whole-slide hematein eosin saffron (HES)-stained image (WSI). After annotating the tumour/non-tumour areas, 256x256 pixel tiles were extracted from the WSIs and used to tra
Medical imaging is the most important tool for detecting complications in the inner body of medicine. Nowadays, with the development of image processing technology as well as changing the size of photos to higher resolution images in the field of digital medical imaging, there is an efficient and accurate system for segmenting this. Real-world images that for a variety of reasons have poor heterogeneity, noise and contrast are essential. Digital image segmentation in medicine is used for diagnostic and therapeutic analysis, which is very helpful for physicians. In this study, we aim at liver cancer photographs, which aim to more accurately detect the lesion or tumor of the liver because accurate and timely detection of the tumor is very important in the survival and life of the patient.The aim of this paper is to simplify the obnoxious study problems related to the study of MR images. The liver is the second organ most generic involved by metastatic disease being liver cancer one of the prominent causes of death worldwide. Without healthy liver a person cannot survive. It is life threatening disease which is very challenging perceptible for both medical and engineering technologist
This paper presents a new approach for classifying 2D histopathology patches using few-shot learning. The method is designed to tackle a significant challenge in histopathology, which is the limited availability of labeled data. By applying a sliding window technique to histopathology slides, we illustrate the practical benefits of transductive learning (i.e., making joint predictions on patches) to achieve consistent and accurate classification. Our approach involves an optimization-based strategy that actively penalizes the prediction of a large number of distinct classes within each window. We conducted experiments on histopathological data to classify tissue classes in digital slides of liver cancer, specifically hepatocellular carcinoma. The initial results show the effectiveness of our method and its potential to enhance the process of automated cancer diagnosis and treatment, all while reducing the time and effort required for expert annotation.
Cancer data, particularly cancer incidence and mortality, are fundamental to understand the cancer burden, to set targets for cancer control and to evaluate the evolution of the implementation of a cancer control policy. However, the complexity of data collection, classification, validation and processing result in cancer incidence figures often lagging two to three years behind the calendar year. In response, national or regional population-based cancer registries (PBCRs) are increasingly interested in methods for forecasting cancer incidence. However, in many countries there is an additional difficulty in projecting cancer incidence as regional registries are usually not established in the same year and therefore cancer incidence data series between different regions of a country are not harmonised over time. This study addresses the challenge of forecasting cancer incidence with incomplete data at both regional and national levels. To achieve this, we propose the use of multivariate spatio-temporal shared component models that jointly model mortality data and available cancer incidence data. We evaluate the performance of these multivariate models using lung cancer incidence dat
Non-invasive colorectal cancer (CRC) screening represents a key opportunity to improve colonoscopy participation rates and reduce CRC mortality. This study explores the potential of the gut-liver axis for predicting colorectal neoplasia through liver-derived radiomic features extracted from routine CT images as a novel opportunistic screening approach. In this retrospective study, we analyzed data from 1,997 patients who underwent colonoscopy and abdominal CT. Patients either had no colorectal neoplasia (n=1,189) or colorectal neoplasia (n_total=808; adenomas n=423, CRC n=385). Radiomics features were extracted from 3D liver segmentations using the Radiomics Processing ToolKit (RPTK), which performed feature extraction, filtering, and classification. The dataset was split into training (n=1,397) and test (n=600) cohorts. Five machine learning models were trained with 5-fold cross-validation on the 20 most informative features, and the best model ensemble was selected based on the validation AUROC. The best radiomics-based XGBoost model achieved a test AUROC of 0.810, clearly outperforming the best clinical-only model (test AUROC: 0.457). Subclassification between colorectal cancer
Cell competition in multicellular organisms has been shown to play a critical role during the development of organisms, cancer progression, and in the establishment and maintenance of tissue homeostasis. Various mechanisms of cell competition have been identified, including active elimination via mechanical forces or induced apoptosis, as well as competition for nutrients and other beneficial factors. A recent experiment demonstrated hallmarks of cell competition, associated with cell cycle dynamics, between liver progenitor cells and colorectal cancer cells [Krotenberg Garcia et al., iScience 27, 109718 (2024)]. However, a mechanistic explanation for this form of competition remains lacking. Here, we present a mean-field model of competition for signaling ligands, coupled with cell cycle dynamics, to provide such an understanding. Our model captures the salient features of the experiment, including population dynamics and cell cycle variations. We demonstrate that secretion of a beneficial factor by cells, coupled with the enhanced uptake efficiency of cancer cells, suffices to reproduce the experimental outcome. Our model, reminiscent of competition for secreted growth factors, p
Automated segmentation tools often encounter accuracy and adaptability issues when applied to images of different pathology. The purpose of this study is to explore the feasibility of building a workflow to efficiently route images to specifically trained segmentation models. By implementing a deep learning classifier to automatically classify the images and route them to appropriate segmentation models, we hope that our workflow can segment the images with different pathology accurately. The data we used in this study are 350 CT images from patients affected by polycystic liver disease and 350 CT images from patients presenting with liver metastases from colorectal cancer. All images had the liver manually segmented by trained imaging analysts. Our proposed adaptive segmentation workflow achieved a statistically significant improvement for the task of total liver segmentation compared to the generic single segmentation model (non-parametric Wilcoxon signed rank test, n=100, p-value << 0.001). This approach is applicable in a wide range of scenarios and should prove useful in clinical implementations of segmentation pipelines.
Postoperative prognostic prediction for colorectal cancer liver metastasis (CRLM) remains challenging due to tumor heterogeneity, dynamic evolution of the hepatic microenvironment, and insufficient multimodal data fusion. To address these issues, we propose 4D-ACFNet, the first framework that synergistically integrates lightweight spatiotemporal modeling, cross-modal dynamic calibration, and personalized temporal prediction within a unified architecture. Specifically, it incorporates a novel 4D spatiotemporal attention mechanism, which employs spatiotemporal separable convolution (reducing parameter count by 41%) and virtual timestamp encoding to model the interannual evolution patterns of postoperative dynamic processes, such as liver regeneration and steatosis. For cross-modal feature alignment, Transformer layers are integrated to jointly optimize modality alignment loss and disentanglement loss, effectively suppressing scale mismatch and redundant interference in clinical-imaging data. Additionally, we design a dynamic prognostic decision module that generates personalized interannual recurrence risk heatmaps through temporal upsampling and a gated classification head, overcomi
Colorectal cancer liver metastasis (CRLM) exhibits high postoperative recurrence and pronounced prognostic heterogeneity, challenging individualized management. Existing prognostic approaches often rely on static representations from a single postoperative snapshot, and fail to jointly capture tumor spatial distribution, longitudinal disease dynamics, and multimodal clinical information, limiting predictive accuracy. We propose DyPro, a deep learning framework that infers postoperative latent trajectories via residual dynamic evolution. Starting from an initial patient representation, DyPro generates a 12-step sequence of trajectory snapshots through autoregressive residual updates and integrates them to predict recurrence and survival outcomes. On the MSKCC CRLM dataset, DyPro achieves strong discrimination under repeated stratified 5-fold cross-validation, reaching a C-index of 0.755 for OS and 0.714 for DFS, with OS AUC@1y of 0.920 and OS IBS of 0.143. DyPro provides quantitative risk cues to support adjuvant therapy planning and follow-up scheduling.
AI in Medical Imaging project aims to enhance the National Cancer Institute's (NCI) Image Data Commons (IDC) by developing nnU-Net models and providing AI-assisted segmentations for cancer radiology images. We created high-quality, AI-annotated imaging datasets for 11 IDC collections. These datasets include images from various modalities, such as computed tomography (CT) and magnetic resonance imaging (MRI), covering the lungs, breast, brain, kidneys, prostate, and liver. The nnU-Net models were trained using open-source datasets. A portion of the AI-generated annotations was reviewed and corrected by radiologists. Both the AI and radiologist annotations were encoded in compliance with the the Digital Imaging and Communications in Medicine (DICOM) standard, ensuring seamless integration into the IDC collections. All models, images, and annotations are publicly accessible, facilitating further research and development in cancer imaging. This work supports the advancement of imaging tools and algorithms by providing comprehensive and accurate annotated datasets.
Embryology has long played a foundational role in shaping our scientific understanding of animal evolution. In recent decades, growing evidence has also highlighted its role in cancer. Despite the indisputable similarities between embryonic development and cancer, there has been limited discussion on the profound embryological implications for the disease. This article explores the understanding of cancer as an embryological and evolutionary phenomenon, offering a fresh perspective on the disease and discussing immediate consequences in the search for therapeutic approaches
Ultrasound (US) is the most commonly used liver imaging modality worldwide. Due to its low cost, it is increasingly used in the follow-up of cancer patients with metastases localized in the liver. In this contribution, we present the results of an interactive segmentation approach for liver metastases in US acquisitions. A (semi-) automatic segmentation is still very challenging because of the low image quality and the low contrast between the metastasis and the surrounding liver tissue. Thus, the state of the art in clinical practice is still manual measurement and outlining of the metastases in the US images. We tackle the problem by providing an interactive segmentation approach providing real-time feedback of the segmentation results. The approach has been evaluated with typical US acquisitions from the clinical routine, and the datasets consisted of pancreatic cancer metastases. Even for difficult cases, satisfying segmentations results could be achieved because of the interactive real-time behavior of the approach. In total, 40 clinical images have been evaluated with our method by comparing the results against manual ground truth segmentations. This evaluation yielded to an
Nanorobots are a promising development in targeted drug delivery and the treatment of neurological disorders, with potential for crossing the blood-brain barrier (BBB). These small devices leverage advancements in nanotechnology and bioengineering for precise navigation and targeted payload delivery, particularly for conditions like brain tumors, Alzheimer's disease, and Parkinson's disease. Recent progress in artificial intelligence (AI) and machine learning (ML) has improved the navigation and effectiveness of nanorobots, allowing them to detect and interact with cancer cells through biomarker analysis. This study presents a new reinforcement learning (RL) framework for optimizing nanorobot navigation in complex biological environments, focusing on cancer cell detection by analyzing the concentration gradients of surrounding biomarkers. We utilize a computer simulation model to explore the behavior of nanorobots in a three-dimensional space with cancer cells and biological barriers. The proposed method uses Q-learning to refine movement strategies based on real-time biomarker concentration data, enabling nanorobots to autonomously navigate to cancerous tissues for targeted drug d